Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03694925 · ClinicalTrials.gov registry record
Diagnostic Utility of a Novel Point-of-Care Test of Calprotectin for Revision Total Knee Arthroplasty
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 156
- Enrollment target
NCT03694925 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 156 participants.
The verdict
NCT03694925 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 156 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate whether there are quantifiable differences in the level of calprotectin in the synovial fluid that allow separation of different modes of joint implant failure (e.g. infected, aseptic loosening). A subset of primary TKA patients (with history of OA) will be included as a baseline.
Interventions
- DIAGNOSTIC_TEST Calprotectin test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2018-10-29 |
| Est. Completion | 2020-03-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03694925
The ClinicalTrials.gov registry entry for NCT03694925 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Calprotectin test is the first listed.
NCT03694925 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03694925 about?
NCT03694925 is a clinical study titled "Diagnostic Utility of a Novel Point-of-Care Test of Calprotectin for Revision Total Knee Arthroplasty". The purpose of this study is to investigate whether there are quantifiable differences in the level of calprotectin in the synovial fluid that allow separation of different modes of joint implant failure (e.g. infected, aseptic loosening). A subset of primary TKA patients (with history of OA) will b...
What is the current status of trial NCT03694925?
This trial is currently completed. The enrollment target is 156 participants. The study started on 2018-10-29. Estimated completion is 2020-03-04.
What interventions are being tested in trial NCT03694925?
The interventions under investigation include: Calprotectin test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03694925?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.